Bird & Bird advised Biomemory on its €17 million fundraising round

Published

Dec 23 2024

Related

Practices

Sectors

Countries

International law firm Bird & Bird advised Biomemory, a French deeptech pioneer in DNA data storage, on its €17 million Series A funding round, with new investors Crédit Mutuel Innovation, Blast.club, Bpifrance, Sorbonne Venture and Adnexus, and its existing shareholders.

Founded in 2021, this innovative deeptech spin-off from CNRS/Sorbonne University’s first objective is to produce DNA printers that can transform binary information into AGTC information (the four types of DNA nucleotide).

Two years after a €5 million seed round, Biomemory plans to use this new funding to expand its team by recruiting promising talent in molecular biology and engineering to accelerate product development and commercialisation. 

The Bird & Bird team advising on the deal consisted of lead partner Félicien Bardsley and associate Céline Sol. 

News & Deals

More News & Deals
News Bird & Bird advises MOL on joint acquisition of Scotland's Port of Nigg

Sep 11 2025

Read More
News Bird & Bird hires industrials, infrastructure and transport expert Eleanor Kerslake as new partner

Sep 08 2025

Read More
Deal Bird & Bird advises Siloco on the acquisition of NOVOCONT and NOVORENT

Sep 05 2025

Read More
Deal Bird & Bird advises Investronic shareholders on Evolem's equity investment

Sep 03 2025

Read More
News Bird & Bird strengthens Polish Energy & Utilities team with new partner hire

Sep 02 2025

Read More
News Bird & Bird boosts regulatory team in Brussels with double partner hire

Sep 01 2025

Read More
More News & Deals

Related capabilities

Corporate Venture Capital Technology & Communications Life Sciences and Healthcare